As inhibition of tumor growth by TAE226 appears to correlate with inhibition of FAK and Akt as a surrogate of IGF-1R signaling pathway, TAE226 represents a novel class of selective and small molecule kinase inhibitor with a potent in vivo activity. Here, AKT1 is linked to neoplasm.